ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Search by Abstract Number Results

  • Abstract Number: 1882 • ACR Convergence 2024

    30-Day Readmission Among Patients with Rheumatoid Arthritis and Their Independent Predictors: Insights from National Readmission Database

    Shobhit Piplani1, Priyanshu Jain2, Vladimir Jelic3, Clement Tagoe4 and Beverly Johnson5, 1Jacobi Medical Center/North Central Bronx Albert Einstein College of Medicine NYC Health and Hospitals, Bronx, NY, 2Jawaharlal Nehru Medical College, Belgaum, Karnataka, India, Bronx, NY, 3Jacobi Medical Center/North Central Bronx, Bronx, NY, 4Albert Einstein College of Medicine, FRESH MEADOWS, NY, 5Albert Einstein College of Medicine, New York, NY

    Background/Purpose: Rheumatoid Arthirits (RA) is associated with heightened morbidity, diminished quality of life, and increased healthcare expenses. This research aims to bridge this gap by…
  • Abstract Number: 1882 • ACR Convergence 2023

    Imaging in Diagnosis, Monitoring and Outcome Prediction of Large Vessel Vasculitis: A Systematic Literature Review Informing the 2023 Update of the EULAR Recommendations

    Philipp Bosch1, Milena Bond2, Christian Dejaco3, Cristina Ponte4, Sarah Mackie5, Louise Falzon6, Wolfgang Schmidt7 and Sofia Ramiro8, 1Medical University of Graz, Graz, Austria, 2Azienda sanitaria dell'Alto Adige, Merano, Italy, 3Department of Rheumatology, Medical University Graz, Graz, Austria; Department of Rheumatology, Hospital of Bruneck (ASAA-SABES), Teaching Hospital of the Paracelsius Medical University, Brunico, Italy, 4Department of Rheumatology, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Lisbon, Portugal, 5Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 6University of Sheffield, Sheffield, United Kingdom, 7Immanuel Krankenhaus Berlin, Berlin, Germany, 8Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Since the development of the EULAR recommendations for the use of imaging in large vessel vasculitis (LVV) in 2017, new data has emerged in…
  • Abstract Number: 1882 • ACR Convergence 2022

    Efficacy of Immune-apheresis in Patients with Inflammatory Myopathies: A Case Series

    Kastriot Kastrati1, Hanien Rajab2, Anna Rader2, Elisabeth Anna Aichner2, Thomas Karonitsch2, Hans-Peter Kiener2, Michael Bonelli3, Daniel Aletaha4 and Helga Radner3, 1Division of Rheumatology, Vienna, Austria, 2Medical University Vienna, Vienna, Austria, 3Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, 4Medical University Vienna, Wien, Austria

    Background/Purpose: Idiopathic inflammatory myopathies (IIM) comprise a heterogenous group of acquired autoimmune diseases characterised by inflammation of muscle and affection of other organs, including lung…
  • Abstract Number: 1882 • ACR Convergence 2021

    Clinical Characteristics and Reliability of a Self-Reported Diagnosis of Large-Vessel Vasculitis

    Tannaz Kermani1, Jason Springer2, Dianne Shaw3, Kalen Young4, Cristina Burroughs5 and Peter Merkel6, 1University of California Los Angeles, Los Angeles, CA, 2Vanderbilt University Medical Center, Franklin, TN, 3Vasculitis Foundation, Chapel Hill, NC, 4Vasculitis Foundation, Kansas City, MO, 5Health Informatics Institute, Tampa, FL, 6University of Pennsylvania, Philadelphia, PA

    Background/Purpose: To compare the clinical characteristics and determine the reliability of a self-reported diagnosis of giant cell arteritis (GCA) or Takayasu’s arteritis (TAK) from an…
  • Abstract Number: 1882 • ACR Convergence 2020

    Are There Any Clues to Predict Bamboo Spine in Axial Spondyloarthritis?

    Pamir Atagündüz1, Sedat Kiraz2, Servet Akar3, Orhan Küçükşahin4, Abdulsamet Erden4, Nihan Coşkun5, Burcu Yağız5, Cemal Bes6, Levent Kılıç7, Ömer Karadağ7, Timuçin Kaşifoğlu8, Hakan Emmungil9, Muhammet Çınar10, Gezmiş Kimyon11, Veli Yazısız12, Askin Ates13, Emine Duygu Ersozlu14, Emel Gönüllü15, Rıdvan Mercan16, İhsan Ertenli2 and Umut Kalyoncu2, 1Marmara University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, İstanbul, Turkey, 2Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey, 3Izmir Katip Celebi University, Izmir, Turkey, 4Yıldırım Beyazıt University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology,, Ankara, Turkey, 5Uludag University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Bursa, Turkey, 6Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Bolu, Turkey, 7Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara,, Ankara, Turkey, 8Eskisehir Osmangazi University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Eskişehir, Turkey, 9Trakya University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Edirne, Turkey, 10University of Health Sciences, Gulhane Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey, 11Hatay Mustafa Kemal University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology,, Hatay, Turkey, 12Akdeniz University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology,, Antalya, Turkey, 13Ankara University, Ankara, Turkey, 14Ministry of Health Adana City Hospital, Adana, Turkey, 15Sakarya University, Department of Internal Medicine, Division of Rheumatology, Sakarya, Turkey, 16Tekirdag Namik Kemal University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology,, Tekirdağ, Turkey

    Background/Purpose: Complete ankylosis of the entire spinal column is a severe condition seen in spondyloarthritis. This study aims to investigate the possible risk factors associated…
  • Abstract Number: 1882 • 2019 ACR/ARP Annual Meeting

    Anti-CCP Antibody and Pain Sensitization in Rheumatoid Arthritis

    Yoon Mun1, Tuhina Neogi 2, Jing Song 3, Dorothy Dunlop 1, Andrew Heisler 1, Marcy Bolster 4, Clifton Bingham 5, Wendy Marder 6, Alyssa Wohlfahrt 7 and Yvonne Lee 8, 1Northwestern University Feinberg School of Medicine, Chicago, IL, 2Boston University School of Medicine, Boston, MA, 3Northwestern University Feinberg School of Medicine, Worthington, OH, 4Massachusetts General Hospital, Boston, MA, 5Johns Hopkins University, Baltimore, 6Division of Rheumatology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, 7Brigham and Woman's Hospital, Boston, MA, 8Northwestern University Feinberg School of Medicine, Chicago

    Background/Purpose: Many patients with RA report persistent pain in the absence of clinically appreciable inflammation. In a mouse model of inflammatory arthritis, mice injected with…
  • Abstract Number: 1882 • 2018 ACR/ARHP Annual Meeting

    Characteristics and Treatment Outcomes of Takayasu Arteritis in a Nationwide, Retrospective Cohort Study in Japan

    Haruhito A. Uchida1, Yoshikazu Nakaoka2, Hajime Yoshifuji3, Takahiko Sugihara4, Yoshiko Watanabe5, Masayoshi Harigai6, Yoshihiro Arimura7 and Mitsuaki Isobe8, 1Department of Chronic Kidney Disease and Cardiovascular Disease, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, 2Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan, 3Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 4Department of Medicine and Rheumatology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan, 5First Department of Physiology, Kawasaki Medical School, Kurashiki, Japan, 6Tokyo Women's Medical University, Division of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Institute of Rheumatology, Tokyo, Japan, 7Kyorin University School of Medicine, First Department of Internal Medicine, Tokyo, Japan, 8Sakakibara Heart Institute, Tokyo, Japan

    Background/Purpose: Takayasu arteritis (TAK) typically affects young women under 40 years old, whereas patients with onset age over 40 years are occasionally observed. It still…
  • Abstract Number: 1882 • 2017 ACR/ARHP Annual Meeting

    Thymus and Activation-Regulated Chemokine (TARC) As Biomarker for IgG4-Related Disease

    Masataka Umeda1,2, Tomoki Origuchi3, Shinya Kawashiri1,4, Tomohiro Koga1,5, Kunihiro Ichinose1, Yushiro Endo1, Sousuke Tsuji1, Ayuko Takatani1, Takashi Igawa1, Toshimasa Shimizu1, Shoichi Fukui1,4, Remi Sumiyoshi1, Ayako Nishino1,6, Naoki Iwamoto1, Mami Tamai1, Hideki Nakamura1 and Atsushi Kawakami1, 1Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 2Medical Education Development Center, Nagasaki University Hospital, Nagasaki, Japan, 3Department of Rehabilitation Sciences, Nagasaki University, Nagasaki, Japan, 4Departments of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 5Center for Bioinformatics and Molecular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki City, Japan, 6Center for Comprehensive Community Care Education, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

    Background/Purpose: TARC, also known as chemokine ligand 17 (CCR17), is expressed in the thymus and is produced by dendritic cells, endothelial cells, keratinocytes and fibroblasts.…
  • Abstract Number: 1882 • 2016 ACR/ARHP Annual Meeting

    Predictors of Response to Methotrexate in Patients with Eosinophilic Fasciitis (Shulman’s Disease)

    Walter A. Sifuentes-Giraldo1, Dolors Grados Canovas2, Marina De Los Riscos Alvarez3, María Pascual Pastor4, Pablo Moreno Fresneda5, Estibaliz Loza6, María J. García Yébenes6, Alejandro Olivé2, Patricia Carreira Delgado3, Francisco J. Narvaez Garcia4, Rosario García-Vicuña7 and Antonio Zea Mendoza1, 1Rheumatology, Hospital Universitario Ramón y Cajal, Madrid, Spain, 2Rheumatology, Hospital Universitario Germans Trias i Pujol, Barcelona, Spain, 3Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, 4Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, 5Rheumatology, Rheumatology Service, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain, 6Instituto de Salud Musculoesquelética (InMusc), Madrid, Spain, 7Rheumatology, Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain

    Background/Purpose:  Eosinophilic fasciitis (EF) is a rare scleroderma-like disorder described in 1974 by Shulman. It is characterized by the acute onset of edema and induration…
  • Abstract Number: 1882 • 2015 ACR/ARHP Annual Meeting

    The Predictive Value of Pulmonary Function Tests to Diagnose Interstitial Lung Disease in Adults with Early Diffuse Cutaneous Systemic Sclerosis

    Elana J. Bernstein1, Veronica J. Berrocal2, Virginia D. Steen3, Victoria K. Shanmugam4,5, Ami A. Shah6, Monique E. Hinchcliff7, Faye N. Hant8, Jessica K. Gordon9, Tracy M. Frech10, Robyn T. Domsic11, Shervin Assassi12 and Dinesh Khanna13, 1Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, 2Div of Rheumatology, University of Michigan, Ann Arbor, MI, 3Rheumatology, Georgetown University Medical Center, Washington, DC, 4Division of Rheumatology, The George Washington University, Washington, DC, 5Director, Division of Rheumatology, The George Washington University, Washington, DC, 6Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 7Rheumatology, Northwestern University, Chicago, IL, 8Dept of Medicine, Medical University of South Carolina, Charleston, SC, 9Rheumatology, Hospital for Special Surgery, New York, NY, 10Div of Rheumatology, University of Utah, Salt Lake City, UT, 11Medicine - Rheumatology, University of Pittsburgh, Pittsburgh, PA, 12Rheumatology, University of Texas Medical School at Houston, Houston, TX, 13Division of Rheumatology, University of Michigan, Ann Arbor, MI

    Background/Purpose: Interstitial lung disease (ILD) is the leading cause of death in patients with systemic sclerosis (SSc). Patients with diffuse cutaneous systemic sclerosis (dcSSc) have…
  • Abstract Number: 1882 • 2014 ACR/ARHP Annual Meeting

    Examination of Patients Newly Diagnosed with Fibromyalgia: Use of Guideline-Recommended Therapies and Opioids in Clinical Practice

    Sonali N. Shah1, Rachel Halpern2, Joseph C. Cappelleri3, Elizabeth T. Masters4, Andrew G. Clair5, Cori Blauer-Peterson2 and Damon Van Voorhis6, 1Health Economics and Outcomes Research, Pfizer, Inc., New York, NY, 2Health Economics and Outcomes Research, Optum, Eden Prairie, MN, 3Biostatistics, Pfizer, Inc., Groton, CT, 4Health Economics and Outcomes Research, Pfizer Inc, New York, NY, 5US Medical Affairs Primary Care, Pfizer, Inc., New York, NY, 6Optum Life Sciences, Eden Prairie, MN

    Background/Purpose: Fibromyalgia (FM) affects 2-5% of adults in the United States. Pregabalin (antiepileptic drug [AED]), and duloxetine and milnacipran (serotonin and norepinephrine reuptake inhibitors), are…
  • Abstract Number: 1882 • 2013 ACR/ARHP Annual Meeting

    Characterizing The C-Type Lectin Domain Family 4, Member C Gene (CLEC4C) Expression In Peripheral Blood From Rheumatoid Arthritis Patients

    Annie Yarwood1, Joanna Cobb2, Kate McAllister1, Joanne Barnes1, Ernst R. Dow3, Michelle A. Penny3, Robert W. Hoffman3 and Anne Barton4,5, 1Arthritis Research UK Epidemiology Unit, Centre for Musculoskeletal Research, Institute of Inflammation and repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom, 2NIHR Manchester Musculoskeletal Biomedical Research Unit, Manchester Academic Health Science Centre, Central Manchester Foundation Trust, Manchester, United Kingdom, 3Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, 4Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, United Kingdom, 5NIHR Manchester Musculoskeletal BRU, Central Manchester Foundation Trust and University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom

    Background/Purpose: A previous hypothesis-seeking study examining baseline phenotypic expression of mRNA in a Phase 2 clinical trial of tabalumab (also known as LA294 or LY2127399)…
  • Abstract Number: 1882 • 2012 ACR/ARHP Annual Meeting

    Predictors of a Favorable Outcome in Patients with Fibromyalgia: Results From the 1-Year Follow-up

    Dong-Jin Park1, Shin-Seok Lee2, Seong-Ho Kim3, Seong-Su Nah4, Ji Hyun Lee5, Seong-Kyu Kim6, Yeon-Ah Lee7, Seung-Jae Hong7, Hyun-Sook Kim8, Hye-Soon Lee9, Hyoun Ah Kim10, Chung-Il Joung11 and Sang-Hyon Kim12, 1Rheumatology, Chonnam National University Medical School, Gwangju, South Korea, 2Dept of Int Med/Rheumatology, Chonnam National University Medical School, Gwangju, South Korea, 3Department of Internal Medicine,, Inje University Haeundae Paik Hospital, Busan, South Korea, 4Rheumatology, Soonchunhyang University, South Korea, 5Division of Rheumatology, Department of Internal Medicine, Maryknoll Medical Center, Busan, South Korea, 6Catholic University of Daegu School of Medicine, Daegu, South Korea, 7Division of Rheumatology, Department of Internal Medicine, Kyung Hee University, Seoul, South Korea, 8Internal Medicine, Chosun University Hospital, Gwangju, South Korea, 9Department of Rheumatology, Hanyang University Guri Hospital, Guri, South Korea, 10Ajou University Hospital, Suwon, South Korea, 11Department of Internal Medicine, Konyang university hospital, Daejeon, South Korea, 12Division of Rheumatology, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, South Korea

    Background/Purpose: To determine the outcomes in Korean patients with fibromyalgia (FM) and identify the prognostic factors associated with improvement at 1-year follow-up. Methods: Forty-eight patients…
Search Again »

Didn't find what you were looking for? Try the Advanced Search »

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology